Reviews Lexiscan


No reviews yet.

Lexiscan Drug Description
Lexiscan®
(regadenoson) Injection for Intravenous Administration
DRUG DESCRIPTION



What are the possible side effects of regadenoson (Lexiscan)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
wheezing, trouble breathing; or
feeling like...
Read All Potential Side Effects for Lexiscan »




Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator
[see CLINICAL PHARMACOLOGY]. Regadenoson is chemically described as adenosine,
2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural
formula is:








The molecular formula for regadenoson is C15H18N8O5•H2O
and its molecular weight is 408.37.
Lexiscan is a sterile, nonpyrogenic solution for intravenous injection. The
solution is clear and colorless. Each 1 mL in the 5-mL vial or pre-filled syringe
contains 0.084 mg of regadenoson monohydrate, corresponding to 0.08 mg regadenoson
on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg
dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate,
150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection,
with pH between 6.3 and 7.7.
Last reviewed on RxList: 1/8/2010




Lexiscan Drug Description
Lexiscan®
(regadenoson) Injection for Intravenous Administration
DRUG DESCRIPTION



What are the possible side effects of regadenoson (Lexiscan)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
wheezing, trouble breathing; or
feeling like...
Read All Potential Side Effects for Lexiscan »




Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator
[see CLINICAL PHARMACOLOGY]. Regadenoson is chemically described as adenosine,
2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural
formula is:








The molecular formula for regadenoson is C15H18N8O5•H2O
and its molecular weight is 408.37.
Lexiscan is a sterile, nonpyrogenic solution for intravenous injection. The
solution is clear and colorless. Each 1 mL in the 5-mL vial or pre-filled syringe
contains 0.084 mg of regadenoson monohydrate, corresponding to 0.08 mg regadenoson
on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg
dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate,
150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection,
with pH between 6.3 and 7.7.
Last reviewed on RxList: 1/8/2010




Lexiscan Drug Description
Lexiscan®
(regadenoson) Injection for Intravenous Administration
DRUG DESCRIPTION



What are the possible side effects of regadenoson (Lexiscan)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
wheezing, trouble breathing; or
feeling like...
Read All Potential Side Effects for Lexiscan »




Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator
[see CLINICAL PHARMACOLOGY]. Regadenoson is chemically described as adenosine,
2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural
formula is:








The molecular formula for regadenoson is C15H18N8O5•H2O
and its molecular weight is 408.37.
Lexiscan is a sterile, nonpyrogenic solution for intravenous injection. The
solution is clear and colorless. Each 1 mL in the 5-mL vial or pre-filled syringe
contains 0.084 mg of regadenoson monohydrate, corresponding to 0.08 mg regadenoson
on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg
dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate,
150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection,
with pH between 6.3 and 7.7.
Last reviewed on RxList: 1/8/2010




Lexiscan Drug Description
Lexiscan®
(regadenoson) Injection for Intravenous Administration
DRUG DESCRIPTION



What are the possible side effects of regadenoson (Lexiscan)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
wheezing, trouble breathing; or
feeling like...
Read All Potential Side Effects for Lexiscan »




Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator
[see CLINICAL PHARMACOLOGY]. Regadenoson is chemically described as adenosine,
2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural
formula is:








The molecular formula for regadenoson is C15H18N8O5•H2O
and its molecular weight is 408.37.
Lexiscan is a sterile, nonpyrogenic solution for intravenous injection. The
solution is clear and colorless. Each 1 mL in the 5-mL vial or pre-filled syringe
contains 0.084 mg of regadenoson monohydrate, corresponding to 0.08 mg regadenoson
on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg
dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate,
150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection,
with pH between 6.3 and 7.7.
Last reviewed on RxList: 1/8/2010




Lexiscan Drug Description
Lexiscan®
(regadenoson) Injection for Intravenous Administration
DRUG DESCRIPTION



What are the possible side effects of regadenoson (Lexiscan)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
wheezing, trouble breathing; or
feeling like...
Read All Potential Side Effects for Lexiscan »




Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator
[see CLINICAL PHARMACOLOGY]. Regadenoson is chemically described as adenosine,
2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate. Its structural
formula is:








The molecular formula for regadenoson is C15H18N8O5•H2O
and its molecular weight is 408.37.
Lexiscan is a sterile, nonpyrogenic solution for intravenous injection. The
solution is clear and colorless. Each 1 mL in the 5-mL vial or pre-filled syringe
contains 0.084 mg of regadenoson monohydrate, corresponding to 0.08 mg regadenoson
on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate or 8.7 mg
dibasic sodium phosphate anhydrous, 5.4 mg monobasic sodium phosphate monohydrate,
150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection,
with pH between 6.3 and 7.7.
Last reviewed on RxList: 1/8/2010





Other reviews about Lexiscan on wordpress

CV Therapeutics Soars on TPG-Axon Financing (CVTX)
  by 247wallst
CV Therapeutics, Inc. (NASDAQ: CVTX) has secured a deal with TPG-Axon Capital, where it will receive up to $185 million in exchange for the rights to 50% of […]


CV Therapeutics Signs Lucrative Deal with TPG-Axon Capital
  by onetime123
Palo Alto-based CV Therapeutics signed a lucrative deal earlier this week with New York-based TPG-Axon Capital in which TPG-Axon Capital, a New York hedge fund, agreed to pay up to $185 […]


Astellas launches hostile takeover for CV Therapeutics
  by Larry Husten
Astellas Pharma announced today that it was launching a hostile takeover for CV Therapeutics, the company that manufactures ranolazine (Ranexa) and regadenoson (Lexiscan).   As we reported back […]


Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)
  by 247wallst
Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash. This deal is via a tender offer and second […]


Gilead, topping Astellas, to acquire CV Therapeutics
  by Larry Husten
Gilead Sciences will acquire CV Therapeutics, makers of ranolazine (Ranexa) and regadenoson (Lexiscan). The announcement comes on the heels of Astella's hostile attempt to acquire CV Therapeutics, as […]


3rd M&A of the week: Gilead acquires CV Therapeutics
  by Tan Adriaan K
Gilead Sciences revealed today its acquisition of cardiovascular drugmaker CV Therapeutics for $1.4bn in cash.  For $20/share, this steps over the $16/share hostile bid of Japan's Astellas Pharma, […]


Gilead Sciences to Buy CV Therapeutics for $1.4 Billion
  by onetime123
Gilead Sciences has agreed to buy Palo Alto-based CV Therapeutics for $1.4 billion dollars. According to SF Gate, Gilead Sciences will pay $20 per share for CV Therapeutics, which […]


last week's 'strategic' merger
  by Jeffrey Seguritan
Last week unraveled a delirious splurge of M&A activity in the pharmaceutical industry, headlined by Merck acquiring Schering-Plough and Roche buying up the remaining 44% of Genentech that […]


FDA MedWatch - December 2009 Drug Safety Labeling Changes
  by irbtipoftheweek
The MedWatch December 2009 Drug Safety Labeling Changes posting includes 28 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, […]


Second week stories
  by Sarah Luna
I started off this week much happier. I feel more in control of what I have to do. I have more specific responsibilities as well. My main purpose […]



Other reviews about Lexiscan on web:

Lexiscan™ (regadenoson) injection is a selective A2A adenosine receptor agonist for pharmacologic stress in radionuclide myocardial perfusion imaging. Welcome to Lexiscan® (regadenoson) injection


Lexiscan (regadenoson) is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Includes Lexiscan side effects, interactions and indications. Lexiscan Information from Drugs.com


Accurate, FDA approved Lexiscan information for healthcare professionals and patients - brought to you by Drugs.com. Lexiscan Official FDA information, side effects and uses.


Lexiscan is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. Welcome to Lexiscan® (regadenoson) injection


It was approved by the United States Food and Drug Administration on April 10, 2008 and it will be marketed under the tradename Lexiscan It has not yet gained approval in the European ... Regadenoson - Wikipedia, the free encyclopedia


Learn about the prescription medication Lexiscan (Regadenoson Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Lexiscan (Regadenoson Injection) Drug Information: Uses, Side ...


The last time I had a chemical stress test, (since… Lexiscan...a new stress test. Should I be so terrified? - Yahoo ...


Welcome to the Lexiscan Imaging Speakers Program. On this Web site, you will be able to download the Lexiscan Imaging Presentation Tool and receive a brief introduction to its ... Welcome to the Lexiscan Imaging Speakers Program


Learn about Lexiscan from the publishers of the Physicians Desk Reference. Find prescription drug information resources including interactions, side effects, symptoms, treatment ... Lexiscan | Prescription Drug Information, Side Effects | PDRHealth


a deno/mm/4-2007/10-2008 1 ADENOSINE OR LEXISCAN STRESS TEST WITH NUCLEAR IMAGING Your physician has ordered either a Lexiscan or Adenosine Nuclear Stress Test. ADENOSINE OR LEXISCAN STRESS TEST WITH NUCLEAR IMAGING





Featured Reviews

Reviews Fluticasone Furoate

Veramyst Drug Description VERAMYST® (fluticasone furoate) Nasal Spray DRUG DESCRIPTION What are the possible side effects of fluticasone nasal (Flonase, Veramyst)? Get emergency medical help if you have any of these signs of...
Read More  |  Review This
Reviews Idarubicin

Idamycin Drug Description Idamycin® (idarubicin hydrochloride) for Injection, USP WARNINGS IDAMYCIN (idarubicin hydrochloride for injection, USP) should be given slowly into a freely flowing intravenous infusion. It must...
Read More  |  Review This
Reviews Ilotycin

Ilotycin Drug Description DRUG DESCRIPTION Ilotycin® (Erythromycin Ophthalmic Ointment, USP) belongs to the macrolide group of antibiotics. It is basic and readily forms a salt when combined with an acid. The base, as crystals or...
Read More  |  Review This
Reviews Gadopentetate Dimeglumine

Magnevist Drug Description MAGNEVIST® (gadopentetate dimeglumine) Injection FOR INTRAVENOUS ADMINISTRATION WARNING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis...
Read More  |  Review This
Reviews Nokian WR G2

it's snowy outside and I have absolutly no problem with my nokian wrg2 tires. They work just like it would be summer. Instant response, no sliding, excellent grip. I really love them :) I already tested them for like 500km and i strongly recommend...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....